BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Genentech Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metastatic Triple-Negative Breast Cancer

  Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company has made the decision to voluntarily withdraw the U.S. accelerated approval for Tecentriq®.

  August 27, 2021

   · 

  14 min read
• Veterinary Orthopedics Treatment Market to Touch $153.61 Billion by 2025 at 6.2% CAGR

  Ascend in creature medical services use and innovative improvements in therapeutics and analytic items are relied upon to help the development of the worldwide veterinary orthopedic treatment market

  August 27, 2021

   · 

  4 min read
• Bone Growth Stimulators Market to Reach $1.87 Billion by 2026 at 5.2% CAGR Says AMR

  Ascend popular for non-intrusive and more secure careful medicines, expansion in number of patients requesting bone growth stimulators, and flood in government consumption on medical services drive the development of the worldwide bone growth stimulators market.

  August 27, 2021

   · 

  4 min read